多学科肿瘤会议（MTC）是多学科癌症治疗的关键工具。近年来，人们对患者参与 MTC 是否以及如何有助于更加以患者为中心的护理做出了科学讨论。本研究旨在确定患者参与 MTC 背景下治疗信心的决定因素。因此，我们对健康素养敏感的沟通、对医疗保健提供者 (HCP) 的信任和治疗信心之间的关联进行了检查。本研究使用了关于患者参与 MTC 的多中心观察性研究“PINTU”的数据。数据收集时间为 2018 年 11 月至 2020 年 2 月。结构方程模型 (SEM) 分析中纳入了经过验证的治疗信心、健康素养敏感沟通和对提供者的信任量表。共有 95 名患者参与了 MTC。该样本泄露了 n = 80 个完整的数据集。 SEM 拟合测量表明所提出的模型拟合良好。分析显示，当添加对提供者的信任的中介作用时，健康素养敏感的沟通与治疗信心之间存在正相关。 MTC 期间以患者为中心的沟通以及参与患者和医疗保健提供者之间的信任关系与治疗呈正相关信心。结果表明了信任的医患沟通和关系的相关性。针对以患者为中心的沟通的医生培训可能是加强患者参与的一种有前景的方法。© 2024 作者。约翰·威利出版的癌症医学

Multidisciplinary tumor conference (MTC) is a key instrument in multidisciplinary cancer care. In recent years, if and how patient participation in MTC can contribute to a more patient-centered care have been scientifically discussed. This study aimed to identify determinants of treatment confidence in the context of patient participation in MTC. Therefore, the association among health literacy-sensitive communication, trust in health-care providers (HCP), and treatment confidence is examined.This study used data from the multicenter, observational study "PINTU" on patient participation in MTC. Data were collected from November 2018 to February 2020. Validated scales for treatment confidence, health literacy-sensitive communication, and trust in providers were included in the structural equation modeling (SEM) analysis.A total of 95 patients participated in MTC. The sample compromised n = 80 completed datasets. The SEM fit measures indicated good fit of the proposed model. The analysis showed a positive association between health literacy-sensitive communication and treatment confidence when adding the mediating effect of trust in providers.Patient-centered communication during MTC in combination with a trustful relationship between participating patients and health-care providers is positively associated with treatment confidence. The results indicated the relevance of a trustful doctor-patient communication and relationship. Trainings for physicians targeting patient-centered communication could be a promising approach to strengthen patient participation.© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.